🇺🇸 FDA
Patent

US 8227246

Compositions of adult disc stem cells for the treatment of degenerative disc disease

granted A61KA61K35/12A61K35/32

Quick answer

US patent 8227246 (Compositions of adult disc stem cells for the treatment of degenerative disc disease) held by DiscGenics, Inc. expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DiscGenics, Inc.
Grant date
Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K35/12, A61K35/32, A61P, A61P19/00